Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Validation of Hemoglobin A1c in Patients With Inflammatory Arthritis Treated With Sulfasalazine
A clinical trial update describes validation of Hemoglobin A1c measurements in patients with inflammatory arthritis treated with sulfasalazi…
-
EMA approval · 2026-02-17EMA Authorised: Inflectra (infliximab) — Pfizer Europe MA EEIG
EMA authorised Inflectra (infliximab) as a biosimilar to Remicade for multiple inflammatory diseases including rheumatoid and psoriatic arth…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Effects of Administration of SCFA in Rheumatoid Arthritis Inadequate Responders [NA]
A clinical trial evaluating the administration of short-chain fatty acids (SCFA) in inadequate responders with rheumatoid arthritis has comp…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants [Phase 1]
A Phase 1 clinical trial is evaluating the safety, tolerability, and pharmacokinetics/pharmacodynamics of Surovatamig in adult participants …
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Safety and Efficacy of TollB-001 Tablets in Moderate to Severe Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial evaluating TollB-001 tablets for safety and efficacy in moderate to severe rheumatoid arthritis is currently recruiti…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
A German real-world study evaluating persistence on Upadacitinib versus TNF inhibitors in adults with moderate-to-severe rheumatoid arthriti…
-
CLINICAL_TRIALS research · 2026-02-17Clinical Trial Update: Insole Optimization for Rheumatoid Arthritis Patients [NA]
A clinical trial update describes an insole optimization study for patients with rheumatoid arthritis, currently not recruiting.
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Rheumatology Patient Registry and Biorepository
This Clinical Trial Update describes a Yale University-led rheumatology patient registry and biorepository that is currently recruiting to c…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System [NA]
Post-market clinical follow-up study of the A.L.P.S. Proximal Humerus Plating System by Zimmer Biomet is currently ACTIVE_NOT_RECRUITING, ex…
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis
A clinical trial update analyzing how T and B cell repertoires change in rheumatoid arthritis patients treated with abatacept (Orencia).
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: an On-demand Program to EmpoweR Active Self-management (OPERAS) [NA]
Clinical trial OPERAS, an on-demand program to empower active self-management for joint disease and rheumatoid arthritis, has completed and …
-
CLINICAL_TRIALS research · 2026-02-13Clinical Trial Update: "Effect of Vitamin E (α-Tocopherol) on Clinical Activity and Inflammation in Rheumatoid Arthritis" [Phase 2, Phase 3]
A Phase 2/3 clinical trial is evaluating whether alpha-tocopherol (Vitamin E) can improve clinical activity and reduce inflammation in rheum…
-
CLINICAL_TRIALS trial_result · 2026-02-12Clinical Trial Update: A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis
A completed clinical trial evaluating adverse events and changes in disease symptoms in Korean participants with rheumatoid arthritis, atopi…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
A long-term follow-up study for participants previously treated with KYV-101; recruitment is ongoing across multiple autoimmune diseases.
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases [NA]
A completed clinical trial update reporting an in vitro study of interleukin-2 muteins on regulatory T cells in patients with autoimmune, al…
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Study of AZD0120 in Autoimmune Diseases [Phase 1]
AZD0120 from AstraZeneca is in Phase 1 testing for autoimmune diseases, including systemic sclerosis, idiopathic inflammatory myopathies, an…
-
CLINICAL_TRIALS trial_result · 2026-02-10Clinical Trial Update: Use of Acthar in Rheumatoid Arthritis (RA) Related Flares [Phase 4]
A Phase 4 clinical trial update shows completion of a study evaluating Acthar for rheumatoid arthritis flares.
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: At-home Ultrasound Localized Therapy for Rheumatoid Arthritis Study [At-home ULTRA Study] [NA]
Clinical trial update shows a study evaluating at-home ultrasound localized therapy for rheumatoid arthritis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: Biochemical Role of Matrix Metalloproteinase -9 in Rheumatoid Arthritis [NA]
This completed Sohag University clinical trial studied the biochemical role of Matrix Metalloproteinase-9 in rheumatoid arthritis.
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Evaluation of CCR6 Gene Expression and Circulating CCL20 Levels as Potential Biomarkers in Rheumatoid Arthritis
This planned clinical study aims to evaluate CCR6 gene expression and circulating CCL20 levels as potential biomarkers for rheumatoid arthri…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Rheumatology Biorepository
A clinical trial registry entry notes a rheumatology biorepository study for rheumatoid arthritis that is currently enrolling by invitation.…
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Improving Hypertension Control in Rheumatoid Arthritis [NA]
A Duke University‑led clinical trial is ongoing to improve hypertension control in patients with rheumatoid arthritis.
-
CLINICAL_TRIALS research · 2026-02-06Clinical Trial Update: Correlation Between Circulating Fibroblast Activation Protein (FAP) and Fibrosis in Two Diseases (Rheumatoid Arthritis and Systemic Sclerosis)
A Sohag University-led clinical trial investigates whether circulating fibroblast activation protein (FAP) levels correlate with fibrosis in…
-
EMA approval · 2026-02-05EMA Authorised: Yuflyma (adalimumab) — Celltrion Healthcare Hungary Kft.
EMA authorised Yuflyma (adalimumab) as a biosimilar of adalimumab for several inflammatory and autoimmune diseases, including rheumatoid art…
-
EMA approval · 2026-02-05EMA Authorised: Tocilizumab STADA (previously Tofidence) (tocilizumab) — STADA Arzneimittel AG
EMA authorised STADA's tocilizumab product (Tocilizumab STADA) for rheumatoid arthritis, juvenile idiopathic arthritis, and COVID-19 infecti…